Adelaide Research & Scholarship: Search

Search

Results 1-10 of 18 (Search time: 0.002 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2016	TBC1D24 genotype-phenotype correlation	Balestrini, S.; Milh, M.; Castiglioni, C.; Lüthy, K.; Finelli, M.; Verstreken, P.; Cardon, A.; Stražišar, B.; Holder, J.; Lesca, G.; Mancardi, M.; Poulat, A.; Repetto, G.; Banka, S.; Bilo, L.; Birkeland, L.; Bosch, F.; Brockmann, K.; Cross, J.; Doummar, D.; et al.
	2017	Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi Survey with patients, caregivers, and health professionals	Sautenet, B.; Tong, A.; Manera, K.; Chapman, J.; Warrens, A.; Rosenbloom, D.; Wong, G.; Gill, J.; Budde, K.; Rostaing, L.; Marson, L.; Josephson, M.; Reese, P.; Pruett, T.; Hanson, C.; O'Donoghue, D.; Tam-Tham, H.; Halimi, J.; Shen, J.; Kanellis, J.; et al.
	2018	A four-gene lincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients	Beck, D.; Thoms, J.; Palu, C.; Herold, T.; Shah, A.; Olivier, J.; Boelen, L.; Huang, Y.; Chacon, D.; Brown, A.; Babic, M.; Hahn, C.; Perugini, M.; Zhou, X.; Huntly, B.; Schwarzer, A.; Klusmann, J.-H.; Berdel, W.; Wörmann, B.; Büchner, T.; et al.
	2013	A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias	Cortes, J.E.; Kim, D.W.; Pinilla-Ibarz, J.; Le Coutre, P.; Paquette, R.; Chuah, C.; Nicolini, F.E.; Apperley, J.F.; Khoury, H.J.; Talpaz, M.; DiPersio, J.; DeAngelo, D.J.; Abruzzese, E.; Rea, D.; Baccarani, M.; Müller, M.C.; Gambacorti-Passerini, C.; Wong, S.; Lustgarten, S.; Rivera, V.M.; et al.
	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma	Yokoyama, S.; Woods, S.; Boyle, G.; Aoude, L.; MacGregor, S.; Zismann, V.; Gartside, M.; Cust, A.; Haq, R.; Harland, M.; Taylor, J.; Duffy, D.; Holohan, K.; Dutton-Regester, K.; Palmer, J.; Bonazzi, V.; Stark, M.; Symmons, J.; Law, M.; Schmidt, C.; et al.
	2015	Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMI	Tsai, V.; Macia, L.; Feinle-Bisset, C.; Manandhar, R.; Astrup, A.; Raben, A.; Lorenzen, J.; Schmidt, P.; Wiklund, F.; Pedersen, N.; Campbell, L.; Kriketos, A.; Xu, A.; Zhou, P.; Jia, W.; Curmi, P.; Angstmann, C.; Lee-Ng, K.; Zhang, H.; Marquis, C.; et al.; Young, M.
	2012	Death adder envenoming causes neurotoxicity not reversed by antivenom - Australian snakebite project (ASP-16)	Johnston, C.; O'Leary, M.; Brown, S.; Currie, B.; Halkidis, L.; Whitaker, R.; Close, B.; Isbister, G.; Nagree, Y.; Ker, F.; Greene, S.; Taylor, M.; Macrokanis, C.; Wilke, G.; Coulson, A.; Barnes, C.; Bonni, R.; Whitake, R.; Halkidis, L.; Isbiste, G.; et al.; de Silva, J.
	2015	TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets	Yeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
	2012	Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature	Kazenwadel, J.; Secker, G.; Liu, Y.; Rosenfeld, J.; Wildin, R.; Cuellar-Rodriguez, J.; Hsu, A.; Dyack, S.; Fernandez, C.; Chong, C.; Babic, M.; Bardy, P.; Shimamura, A.; Zhang, M.; Walsh, T.; Holland, S.; Hickstein, D.; Horwitz, M.; Hahn, C.; Scott, H.; et al.
	2015	A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults	Perez-Andreu, V.; Roberts, K.; Xu, H.; Smith, C.; Zhang, H.; Yang, W.; Harvey, R.; Payne-Turner, D.; Devidas, M.; Cheng, I.; Carroll, W.; Heerema, N.; Carroll, A.; Raetz, E.; Gastier-Foster, J.; Marcucci, G.; Bloomfield, C.; Mrozek, K.; Kohlschmidt, J.; Stock, W.; et al.